Eric P. Berg
7 Papers
266 Citations
Eric P. Berg is an academic researcher. The author has contributed to research in topics: Fixation (surgical) & Biomaterial. The author has an hindex of 5, co-authored 7 publications.
Chat about Author
Papers
Patent
Mucoadhesive drug delivery devices and methods of making and using thereof
David B. Masters,Eric P. Berg +1 more
- 08 Dec 2004
TL;DR: In this paper, the authors present a method of preparation and use of a mucoadhesive drug delivery device, which is composed of one or more biocompatible purified proteins combined with a solvents and a number of muco-adhesive agents.
82
Patent
Protein biomaterials and biocoacervates and methods of making and using thereof
David B. Masters,Eric P. Berg +1 more
- 26 Aug 2004
TL;DR: In this article, the methods of making and using protein biocoacervates and biomaterials are described. And the present paper relates to protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biomaterial devices.
82
Patent
Biocompatible protein particles, particle devices and methods thereof
David B. Masters,Eric P. Berg +1 more
- 12 Oct 2005
TL;DR: In this paper, the authors have proposed a method for the preparation and use of biocompatible protein particles and devices derived from such particles comprising one or more purified proteins combined with a set of solvents.
52
Patent
Encapsulated or coated stent systems
David B. Masters,Eric P. Berg +1 more
- 17 Jun 2005
TL;DR: A stent system comprising zero or more inner stents inserted into an outer stent is defined in this article, where the inner stent and outer stents are separated and/or encapulated by a protein-based material of a protein matrix.
39
Patent
Biomatrix structural containment and fixation systems and methods of use thereof
David B. Masters,Eric P. Berg +1 more
- 29 Apr 2003
TL;DR: The containment and fixation system of the present invention generally includes a biomatix sleeve, biomatrix particles or combinations thereof made of a biomATrix material as mentioned in this paper, which is comprised of one or more biocompatible proteins and one OR more biOCompatible solvents.
11